The first and only SARS-CoV-2 test with Emergency Use Authorization (EUA) for a Locker System

As SARS-CoV-2 continues to coexist in our communities, the demand for quick and accurate PCR diagnostic testing remains. But the need to administer testing and supervise collection pays a heavy toll on the staff of pharmacies and urgent care centers, leaving less time to focus on core patient needs. This strains our healthcare system and results in communities suffering from limited access to testing.

Introducing the Helix SARS-CoV-2 Test and Locker System

Helix is proud to offer the first and only SARS-CoV-2 test with Emergency Use Authorization (EUA) for a Locker System which allows authorized distributors to provide the Helix COVID-19 Self-Collection Kit for unsupervised self-collection at a locker site.

Clear benefits for you and your organization


Reduces on-site staffing needed to enable greater focus on core healthcare services for patients


Provides results within the next day or less from receipt of order to ensure they’re as useful as possible


Facilitates better community access to testing due to greater convenience and flexibility

Here’s how it works for your customers

Customer requests
a Helix SARS-CoV-2
test on your website
or in person

If eligible, customer is
assigned a locker
and code, with
directions to the site

Customer retrieves
test kit from locker
and self-collects
their sample

Customer packages
sample and deposits
it at the designated
drop-off site

Results are available
within the next
day or less

Helix also offers testing options for individuals through on-site supervised and unsupervised self-collection. Patients that qualify for testing have signs or symptoms of COVID-19 identified by a health care practitioner.

An end-to-end COVID-19 test system

A highly scalable solution to detect active infections

Easy self-collection
using lower
nasal swabs

Unsupervised
on-site sample
collection

Authorized for use
in symptomatic
individuals

Next-day results
(from when the
order is placed)

Results sent
to ordering HCP
and patient

Intended Use: Helix SARS-CoV-2 Test

*two-sided 96% CI


The clinical performance of the Helix SARS-CoV-2 Test was evaluated using leftover anterior nasal swab specimens that were collected in 0.85% saline from individuals suspected of COVID-19 by a healthcare provider. A total of 45 positive and 62 negative samples that were previously tested with an FDA authorized RT-PCR assay were used in this study.

The Helix SARS-CoV-2 Test is an in vitro diagnostic real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal swab specimens that are self-collected without supervision using the Helix COVID-19 Self-Collection Kit by individuals 18 years or older who are suspected of COVID-19 by a healthcare provider.

Get in touch

To learn more about our COVID-19 response & viral surveillance, complete this form and we’ll be in touch soon.
If you have questions about your COVID-19 test result, please email support@helix.com

Exciting!

This could be the beginning of something big. A member of our team will send you a welcome email soon.

*Required fields